Td Waterhouse Canada Inc. Aim Immuno Tech Inc. Transaction History

Td Waterhouse Canada Inc.

$14.8 Trillion
Q2 2024

A detailed history of Td Waterhouse Canada Inc. transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Td Waterhouse Canada Inc. holds 170 shares of AIM stock, worth $42. This represents 0.0% of its overall portfolio holdings.

Number of Shares

170

Holding current value

$42

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$0.35 - $0.61 $59 - $103	170 New	170 $118,000
Q1 2024 May 10, 2024	SELL	$0.33 - $0.48 $56 - $81	-170 Closed	0 $0
Q4 2021 Nov 13, 2023	BUY	$0.92 - $1.96 $156 - $333	170 New	170 $220,000

Others Institutions Holding AIM

# of Institutions

Shares Held

8.44M

Call Options Held

Put Options Held

Armistice Capital, LLC New York, NY

4.08M
Shares

$1.02 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

1.99M
Shares

$497,176
0.0% of portfolio
Black Rock Inc. New York, NY

698K
Shares

$174,566
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

401K
Shares

$100,256
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

229K
Shares

$57,202
0.0% of portfolio

View Full List

About AIM ImmunoTech Inc.

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $12M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

More about AIM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

News

Stay updated on Td Waterhouse Canada Inc. with notifications on news.

Account